Faced with Clara's refusal and the tough attitude she clearly expressed, Moiya was also considering the pros and cons.

Originally, the price at which Moiya purchased Amgen Pharmaceuticals' stock was relatively low. Now, at a premium of 20%, the premium alone almost covers the purchase cost, so Moiya was very tempted.

"Are you sure you want to use cash for the acquisition and pay the corresponding amount within three days after signing the contract, Ms. Pollitt?" Moiya asked Clara.

Clara smiled, she had already got the answer she wanted from Moiya's inquiry.

"Yes, Ms. Martha." Clara answered affirmatively.

If the two parties sign the contract, the five major capital groups behind her will actually pay the corresponding funds as soon as possible to complete the corresponding transaction, so as to get Amgen Pharmaceuticals' stock as soon as possible.

"When will the contract be signed on 210?" Moiya asked after making a decision.

Clara answered affirmatively, "If it is convenient for you, Ms. Martha, we can sign the contract now."

"No problem!" Moiya agreed directly.

Since the decision has been made, Moiya has no intention of delaying any longer. Anyway, the 20% premium has satisfied her.

After the two parties confirmed the transaction agreement, they left the cafe together and chose to sign the agreement in a business suite of a hotel again.

In the free capital market of Bald Eagle, the stock transfer agreement is very simple. In more than an hour, the two parties completed the work from signing to payment and equity transfer.

"Ms. Pollitt, congratulations on becoming a shareholder of Amgen Pharmaceuticals!" Moiya stretched out his right hand and shook hands with Clara.

This was her last test. She wanted to see which party Clara worked for.

Clara responded without a single leak, "Thank you Ms. Martha for your blessing!"

Seeing that no relevant information could be obtained, Moiya did not continue to be curious. Anyway, the agreement between the two parties had been signed. No matter who Clara's white glove was, it had nothing to do with her.

Moiya declined Clara's invitation to the dinner. She had her own celebration.

After all, after the two parties signed the agreement, she had received a full 4.2 billion US dollars in cash. She still had a lot of things to do next, including how to reasonably declare taxes, the next wealth arrangement, and future life planning.

Besides, Moiya also knew that Clara was just a polite invitation, not a real invitation, so why bother?

After the two parties left, Clara continued to contact the second shareholder of Amgen Pharmaceutical Company selected by the five major capital groups to prepare for the second negotiation.

There is not only one white glove like Clara. The five major capital groups arranged a considerable number of white gloves to obtain Amgen Pharmaceutical Company's shares off-site.

When the five major capital groups take actionAt that time, a shareholder of Amgen Pharmaceuticals (bafh) who had a good relationship with Williams contacted Williams.

"William, I have something to tell you." Hiram Dart took the initiative to contact Williams.

Hiram Dart was a founding employee of Amgen Pharmaceuticals. He was the senior vice president in charge of marketing and was a senior executive of Amgen Pharmaceuticals.

Hiram held 18 million shares of Amgen Pharmaceuticals, accounting for more than 3.6% of the shares. Naturally, he was also targeted by the five major capital groups, trying to obtain his shares.

Williams responded casually, "What's the matter?"

"Someone just contacted me and hoped to acquire my shares at a price of $300 per share." Hiram said quickly.

"Today, there are also people in the market who are buying our company's shares on a large scale. You should know that, right?" Hiram added.

Williams said affirmatively, "I know."

"Who wants to buy your shares?" Williams asked back.

"Elliot Glaister, an independent investor who has risen on Wall Street in recent years, has operated multiple acquisitions before. You should have heard of his name." Hiram responded.

"It's this person? But the scale of his previous operations did not exceed $1 billion. Now he is eyeing your stocks?" Williams was a little surprised.

"There are rumors that this Elliot is actually a white glove, but we don't know which white glove it is." Hiram speculated.

"This time he contacted me and wanted to acquire my stocks, which proves the rumors. After all, he, an independent investor, certainly can't come up with the relevant funds or resources." Hiram added.

"William, do you have any thoughts on this acquisition? Do you want to start the poison pill plan?" Hiram added.

The so-called poison pill plan is also called equity dilution anti-takeover measures.

The general meaning is that when a company faces a hostile takeover, especially when the hostile acquirer holds 10% to 20% of the shares, in order to ensure that the company is not maliciously acquired, a large number of new shares are issued at a low price. .

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like